Back to LYEL
GEODE CAPITAL MANAGEMENT, LLC → LYEL
GEODE CAPITAL MANAGEMENT, LLC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
10
Latest value
$386K
Q3 2026
Peak value
$4.1M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.7M |
| Q3 2025 | $380K |
| Q4 2025 | $4.1M |
| Q4 2025 | $952K |
| Q1 2026 | $2.7M |
| Q1 2026 | $642K |
| Q2 2026 | $3.7M |
| Q2 2026 | $653K |
| Q3 2026 | $2.3M |
| Q3 2026 | $386K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $386K | 39.4K | — | — |
| Q3 2026 | $2.3M | 235.2K | — | — |
| Q2 2026 | $653K | 46.5K | — | — |
| Q2 2026 | $3.7M | 264.2K | — | — |
| Q1 2026 | $642K | 32.0K | — | — |
| Q1 2026 | $2.7M | 135.0K | — | — |
| Q4 2025 | $952K | 30.9K | — | — |
| Q4 2025 | $4.1M | 132.1K | — | — |
| Q3 2025 | $380K | 23.4K | — | — |
| Q3 2025 | $1.7M | 106.9K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M